On April 3, 2015, Samsung Pharmaceutical Co., Ltd. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,233 KRW | -2.30% | -4.49% | -12.12% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
11,130 KRW | +1.55% | +0.45% | 320M | ||
4,450 KRW | +1.83% | +1.83% | 34.32M | ||
1,633 KRW | +0.49% | -0.18% | 112M | ||
1st Jan change | Capi. | |
---|---|---|
-12.12% | 36.67M | |
+19.08% | 3.17B | |
+12.82% | 1.77B | |
-15.38% | 1.21B | |
+22.12% | 814M | |
+8.13% | 655M | |
+35.53% | 570M | |
-1.73% | 508M | |
+39.44% | 510M | |
+76.80% | 335M |
- Stock Market
- Equities
- A246690 Stock
- News T.S. Investment Corporation
- Samsung Pharmaceutical Co., Ltd. announced that it has received KRW 15.1 billion in funding from GemVax & Kael Co., Ltd. and other investors.